| Literature DB >> 15307186 |
Mark Rutz1, Jochen Metzger, Tanja Gellert, Peter Luppa, Grayson B Lipford, Hermann Wagner, Stefan Bauer.
Abstract
Toll-like receptors (TLR) recognize bacterial and viral components, but direct interaction of receptor and ligand is unclear. Here, we demonstrate that TLR9 binds directly and sequence-specifically to single-stranded unmethylated CpG-DNA containing a phosphodiester backbone. TLR9-CpG-DNA interaction occurs at the acidic pH (6.5-5.0) found in endosomes and lysosomes. By sequence comparison we identified a potential CpG-DNA binding domain homologous to that described for methyl-CpG-DNA binding proteins. Amino acid substitutions in this region abrogated CpG-DNA binding and led to loss of NF-kappaB activation. Furthermore, chloroquine and quinacrine, therapeutic agents for autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus, directly blocked TLR9-CpG-DNA interaction but not TLR2-Pam3Cys binding. Our results demonstrate direct binding of TLR9 to CpG-DNA and suggest that the therapeutic activity of chloroquine and quinacrine in autoimmune diseases may be due to its activity as a TLR9 antagonist and inhibitor of endosomal acidification. Copyright 2004 Wiley-VCH Verlag GmbH & Co.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15307186 DOI: 10.1002/eji.200425218
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532